Back to Trades
Sell4
Kiniksa Pharmaceuticals International, plc
KNSA
Total Value
$629.0K
Net $514.2K sold
Sales
$514.2K
2 transactions
Company Information
- Company Name
- Kiniksa Pharmaceuticals International, plc
- Ticker Symbol
- KNSA
- CIK
- 0001730430
Insider Information
- Name
- Tessari Eben
- Role
- Insider
- Location
- LONDON, X0
Filing Details
- Filing Date
- Nov 19, 2025
- Transaction Date
- Nov 17, 2025
- Accession Number
- 0001867899-25-000009
- Form Type
- 4
- Net Trading Amount
- -$514.2K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Nov 17, 2025 | Class A Ordinary Share | 6,500 | $8.83 | Exercise | $57.4K |
| Nov 17, 2025 | Class A Ordinary Share | 645 | $40.08 | Sale | $25.9K |
| Nov 17, 2025 | Class A Ordinary Share | 11,825 | $41.30 | Sale | $488.4K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Nov 17, 2025 | Derivative | 6,500 | $8.83 | Exercise | $57.4K |
Footnotes
- (F1)This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.
- (F2)This transaction was executed in multiple trades through a broker-dealer at prices ranging between $39.61 and $40.585. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- (F3)This transaction was executed in multiple trades through a broker-dealer at prices ranging between $40.61 and $41.60. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- (F4)The option is fully vested and exercisable.